Varex Imaging Corp Files 8-K
Ticker: VREX · Form: 8-K · Filed: Sep 11, 2024 · CIK: 1681622
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: VREX
TL;DR
Varex Imaging filed an 8-K on Sept 11, 2024. Details TBD.
AI Summary
On September 11, 2024, Varex Imaging Corporation filed an 8-K report. The filing primarily concerns "Other Events" and does not detail specific transactions or financial figures within the provided text. The report confirms Varex Imaging Corporation's legal name, incorporation in Delaware, and its principal executive offices located at 1678 S. Pioneer Road, Salt Lake City, Utah.
Why It Matters
This 8-K filing serves as an official notification to the SEC and investors about significant corporate events, though the specific nature of these events is not detailed in the provided excerpt.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain information that would indicate a specific risk.
Key Players & Entities
- Varex Imaging Corporation (company) — Registrant
- September 11, 2024 (date) — Date of Report
- 1678 S. Pioneer Road, Salt Lake City, Utah 84104 (location) — Principal executive offices
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is September 11, 2024.
What is the full legal name of the registrant?
The exact name of the registrant is Varex Imaging Corporation.
In which state was Varex Imaging Corporation incorporated?
Varex Imaging Corporation was incorporated in Delaware.
What is the address of Varex Imaging Corporation's principal executive offices?
The address of the principal executive offices is 1678 S. Pioneer Road, Salt Lake City, Utah 84104.
What is the Commission File Number for Varex Imaging Corporation?
The Commission File Number for Varex Imaging Corporation is 001-37860.
Filing Stats: 680 words · 3 min read · ~2 pages · Grade level 14.5 · Accepted 2024-09-11 16:23:43
Key Financial Figures
- $50,000,000 — 50% of Consolidated Net Income and (ii) $50,000,000 (previously limited to only 50% of Cons
- $200,000,000 — h currently total and are not to exceed $200,000,000. For the fourth quarter of fiscal 2024
- $150,000,000 — and with Cash Management Banks; and (b) $150,000,000 (rather than the prior $100,000,000). T
- $100,000,000 — (b) $150,000,000 (rather than the prior $100,000,000). The modification only applies to the
Filing Documents
- vrex-20240911.htm (8-K) — 26KB
- 0001681622-24-000083.txt ( ) — 149KB
- vrex-20240911.xsd (EX-101.SCH) — 2KB
- vrex-20240911_lab.xml (EX-101.LAB) — 22KB
- vrex-20240911_pre.xml (EX-101.PRE) — 13KB
- vrex-20240911_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events On September 11, 2024 , Varex Imaging Corporation (the "Company") announced that it has amended its senior secured revolving credit agreement, dated as of March 26, 2024 (the "Credit Agreement") with Zions Bancorporation, N.A. DBA Zions First National Bank ("Zions"), as administrative and collateral agent, the lenders named therein, the issuing banks named therein, and Zions, as lead arranger and bookrunner. Unless indicated otherwise, defined terms have the meaning set forth in the Credit Agreement. The amendment makes the following changes: The definition of Payment Conditions is modified to allow for the flexibility to make restricted payments relating to the Company's convertible notes when the Consolidated Net Leverage Ratio exceeds 2.50:1:00 in an amount equal to the greater of (i) 50% of Consolidated Net Income and (ii) $50,000,000 (previously limited to only 50% of Consolidated Net Income). The definition of Consolidated Fixed Charge Coverage Ratio ("FCCR") is modified to allow for payments on the convertible notes to be excluded from the covenant measurement to account for any prepayments or payment in full on convertible notes, which currently total and are not to exceed $200,000,000. For the fourth quarter of fiscal 2024 and the first and second quarters of fiscal 2025, the definition of Consolidated Total Net Indebtedness will provide that the total indebtedness is allowed to be reduced by the lesser of (a) the aggregate amount of unrestricted cash and cash equivalents held under deposit control agreements and with Cash Management Banks; and (b) $150,000,000 (rather than the prior $100,000,000). The modification only applies to the calculation of the Consolidated Total Net Leverage Ratio itself for purposes of financial covenant compliance and does not apply to any determination that is made with respect to definition of Payment Conditions or any determination that is made with respect to that of the Applicable Margin, which is
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VAREX IMAGING CORPORATION Dated: September 11, 2024 By: /s/ KIMBERLEY E. HONEYSETT Kimberley E. Honeysett Senior Vice President, Chief Legal Officer and Corporate Secretary